# ClinBrain

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/clinbrain

- Industry: Healthcare IT
- Headquarters: Shanghai, China
- Website: www.clinbrain.com
- Total disclosed funding: $52M
- Latest round: Series C (Oct 25, 2022)
- Investors on record: 11

## About

Established in 2013 and based in Shanghai, China, ClinBrain is a medical big data service provider that provides clinical data center, hospital information integration platform and hospital operation and management system.

In 2016, the company was certificated as National Software Company. In 2018, the company raised CNY 68 million in the A round of funding led by Royal Sea Capital. In the same year, the company was authorized by government, certificating as National Advanced Technology Firm. In 2020, the company finished the B round of funding led by Genilink Capital. Investors in the B round includes Jiaxing Guangrun Equity Investment Fund Management, who also invested in the A round in 2018. Through 2020 to 2022, the company finished its B and C round of funding, raising over CNY 200 billion.

The company's products are mainly software for different medical usages, including clinic data repository (CDR), data maintainence, research data management, and electrical medical record evaluation.

## Funding rounds

- Series C, Oct 25, 2022, $28M — Legend Capital, Shanghai Guohe Capital
- Series B, Sep 25, 2020, $15M — MED-FINE Capital, Langcheng Capital, Qianhai Ark Capital, Genilink Capital, Jiaxing Guangrun Equity Investment Fund Management
- Series A, Sep 3, 2018, $9.9M — Real Power Capital, Kingyee, Royal Sea Capital, Huafang Capital, Jiaxing Guangrun Equity Investment Fund Management

## Investors

- Real Power Capital (https://capitalatlas.ai/funds/real-power-capital) — Series A
- Kingyee — Series A
- Royal Sea Capital (https://capitalatlas.ai/funds/royal-sea-capital) — Series A
- Huafang Capital (https://capitalatlas.ai/funds/huafang-capital) — Series A
- Jiaxing Guangrun Equity Investment Fund Management — Series A, Series B
- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Series B
- Langcheng Capital (https://capitalatlas.ai/funds/langcheng-capital) — Series B
- Qianhai Ark Capital (https://capitalatlas.ai/funds/qianhai-ark-capital) — Series B
- Genilink Capital (https://capitalatlas.ai/funds/genilink-capital) — Series B
- Legend Capital — Series C
- Shanghai Guohe Capital (https://capitalatlas.ai/funds/shanghai-guohe-capital) — Series C